| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0004 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |